Hikal Limited Share Price

Equities

HIKAL

INE475B01022

Pharmaceuticals

Market Closed - Bombay S.E. 03:30:50 31/05/2024 pm IST 5-day change 1st Jan Change
284.9 INR +0.21% Intraday chart for Hikal Limited -3.24% -6.13%
Sales 2024 1.78TCr 21Cr Sales 2025 * 2TCr 24Cr Capitalization 3.51TCr 42Cr
Net income 2024 70Cr 83.44L Net income 2025 * 113.8Cr 1.36Cr EV / Sales 2024 1.83 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.75 x
P/E ratio 2024
47 x
P/E ratio 2025 *
30.8 x
Employees -
Yield 2024
0.45%
Yield 2025 *
0.32%
Free-Float 30.92%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.21%
1 week-3.24%
1 month-5.86%
3 months+2.06%
6 months+0.21%
Current year-6.13%
More quotes
1 week
282.25
Extreme 282.25
296.10
1 month
275.95
Extreme 275.95
309.95
Current year
260.65
Extreme 260.65
331.05
1 year
258.60
Extreme 258.6
331.05
3 years
215.65
Extreme 215.65
742.00
5 years
57.00
Extreme 57
742.00
10 years
57.00
Extreme 57
742.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 01/96/01
Founder 76 08/88/08
Director of Finance/CFO - -
Members of the board TitleAgeSince
Founder 76 08/88/08
Chief Executive Officer 50 01/96/01
Director/Board Member 72 05/92/05
More insiders
Date Price Change Volume
31/24/31 284.9 +0.21% 4,783
30/24/30 284.3 -1.95% 10,929
29/24/29 290 -0.46% 4,110
28/24/28 291.3 -0.09% 6,495
27/24/27 291.6 -0.98% 8,415

Delayed Quote Bombay S.E., May 31, 2024 at 03:30 pm IST

More quotes
Hikal Limited is an India-based company, which is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Pharmaceuticals segment produces active pharmaceutical ingredients. Its facilities are in Jigani, Bangalore and Panoli, Gujrat. The Crop protection segment produces pesticides and herbicides. Its facilities are in Taloja, Mahad, Maharashtra and Panoli, Gujarat. Its human health product categories include anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-viral, anti-inflammatory, analgesic and anti-parasitic. Its animal health product categories include anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone and NSAID. Its crop protection product categories include algaecide, biocide, fungicide, herbicide, insecticide and intermediate.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
284.9 INR
Average target price
347.5 INR
Spread / Average Target
+21.97%
Consensus

Quarterly revenue - Rate of surprise